Redhill Biopharma
RDHL
#10468
Rank
โ‚น0.36 B
Marketcap
โ‚น109.11
Share price
0.43%
Change (1 day)
-82.71%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น63,381. In 2017 the company made an earnings per share (EPS) of -โ‚น2,26,360 a decrease over its 2016 EPS that were of -โ‚น1,99,197.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,26,36013.64%
2016-โ‚น1,99,1979.12%
2015-โ‚น1,82,54568.01%
2014-โ‚น1,08,653-25.93%
2013-โ‚น1,46,681

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น335.53-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น687.57-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น325.59-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
โ‚น110.46-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
โ‚น57.04-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel